XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 7,139 $ 1,034 $ 11,926 $ 1,727
General and administrative 1,895 1,986 3,963 3,807
Total operating expenses 9,034 3,020 15,889 5,534
Loss from operations (9,034) (3,020) (15,889) (5,534)
Other income (expense), net 138 (15) 240 (68)
Net loss $ (8,896) $ (3,035) $ (15,649) $ (5,602)
Net loss per share - basic $ (0.42) $ (0.21) $ (0.74) $ (0.38)
Net loss per share - diluted $ (0.42) $ (0.21) $ (0.74) $ (0.38)
Weighted average shares outstanding, basic 21,046,831 14,761,261 21,026,866 14,760,538
Weighted average shares outstanding, diluted 21,046,831 14,761,261 21,026,866 14,760,538
Comprehensive Loss:        
Net loss $ (8,896) $ (3,035) $ (15,649) $ (5,602)
Unrealized gain on investment, net. 1   1  
Comprehensive loss $ (8,895) $ (3,035) $ (15,648) $ (5,602)